Subscribe free

Cytoreductive Surgery & Peritoneum ·

Cytoreductive surgery improves survival in colorectal peritoneal metastases.

In patients with colorectal peritoneal metastases, cytoreductive surgery has shown significant survival benefits, regardless of the use of intraperitoneal chemotherapy. Despite recent challenges to the efficacy of intraperitoneal treatments, the comprehensive review indicates that surgical intervention remains a crucial component in managing this aggressive form of cancer. The study emphasizes a critical analysis of current treatment protocols and the need for enhanced strategies to improve patient outcomes in colorectal cancer with peritoneal spread.

Review by Brown ZJ, Krell M (…) Pawlik TM et 3 al. in J Gastrointest Surg

Copyright © 2024. Published by Elsevier Inc.

read the whole article in J Gastrointest Surg

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in Cytoreductive Surgery & Peritoneum.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

Specialty newsletters: every new paper in your field, as a list of titles linked to the source. Daily Selection: the five that matter, cut to their key points.

FreeNo spamOne-click unsubscribe

More in Cytoreductive Surgery & Peritoneum

The latest stitches

Ann Surg Oncol28 Aug 2026

Prophylactic HIPEC Improves Survival in Advanced Colorectal Cancer

Prophylactic hyperthermic intraperitoneal chemotherapy (HIPEC) significantly enhances peritoneal metastasis-free survival and disease-free survival in patients with locally advanced colorectal cancer, though overall survival rates and complication rates remain unchanged.

All papers in Cytoreductive Surgery & Peritoneum →